US FDA Wants To Predict ANDA Complete Response Responses
Executive Summary
Generic industry, FDA discuss potential ways to increase transparency so agency can better estimate when – and even whether – an ANDA receiving a complete response will be returned.
You may also be interested in...
Trump's Budget Request To Include ANDA Exclusivity Changes
180-day exclusivity would begin when a second ANDA is approvable, rather than at first-generic's launch, a potentially major change to the Hatch-Waxman framework if implemented.
Pay-For-Delay, REMS Reform Legislation Making (Slow) Progress In House
CREATES Act gets a hearing, but Judiciary committee members spend much of their time asking questions about basic concepts of FDA review.
ANDA Approval Times Get Optimistic Estimate In Budget Request
US FDA has historically overestimated generic review performance in budget requests, but recently underestimated the number of ANDAs it expects to approve.